Data from Genomic Alterations of Anaplastic Lymphoma Kinase May Sensitize Tumors to Anaplastic Lymphoma Kinase Inhibitors
Ultan McDermott(AstraZeneca (United Kingdom)), Jeffrey Settleman(Enzo Life Sciences (United States)), Nathanael S. Gray(Stanford University), Georgiana Kuhlmann(Harvard University), A. John Iafrate(Massachusetts General Hospital), Lori Dowell(Harvard University), Shyamala Maheswaran(Massachusetts General Hospital), Wenjun Zhou(Jiangxi University of Finance and Economics), James G. Christensen, Patricia Greninger(Harvard University), Hwan Geun Choi(Harvard University), Lindsey E. Ulkus(Harvard University), Shannon L. Smith(Harvard University), Daniel A. Haber(Howard Hughes Medical Institute), Marie Classon(Pfizer (United States)), Toshi Shioda(Center for Cancer Research)
Cited by 0
Related Papers
<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
|Science|2007|4.5k
Isolation of rare circulating tumour cells in cancer patients by microchip technology
|Nature|2007|3.5k
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
|Endocrine Reviews|2012|3.1k